Robert Will's Insider Trades & SAST Disclosures
Robert Will's most recent trade in Regional Management Corp was a trade of 1,337 Common Stock done at an average price of $30.0 . Disclosure was reported to the exchange on May 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert Will.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Regional Management Corp | Robert William Beck | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.02 per share. | 14 May 2025 | 1,337 | 95,833 (0%) | 0% | 30.0 | 40,137 | Common Stock |
| Regional Management Corp | Robert William Beck | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.03 per share. | 12 May 2025 | 2,838 | 97,170 (0%) | 0% | 30.0 | 85,225 | Common Stock |
| Regional Management Corp | Robert William Beck | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.13 per share. | 12 May 2025 | 1,665 | 100,008 (0%) | 0% | 30.1 | 50,166 | Common Stock |
| Donnelley Financial Soluti... | Robert Kirk Williams | Chief People & Admin Officer | Sale of securities on an exchange or to another person at price $ 52.09 per share. | 07 May 2025 | 4,703 | 68,815 (0%) | 0% | 52.1 | 244,979 | Common Stock |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.31 per share. | 04 Apr 2025 | 2,070 | 41,530 (0%) | 0% | 26.3 | 54,462 | Ordinary Shares |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2025 | 2,070 | 4,140 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.31 per share. | 04 Apr 2025 | 1,079 | 40,451 (0%) | 0% | 26.3 | 28,388 | Ordinary Shares |
| Regional Management Corp | Robert William Beck | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 50,437 | 50,437 | - | - | Restricted Stock Units | |
| Couchbase Inc | William Robert Carey | Interim CFO & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.55 per share. | 17 Mar 2025 | 1,670 | 97,080 | - | 13.5 | 22,627 | Common Stock |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 9.25 per share. | 10 Mar 2025 | 4,176 | 685,702 (3%) | 0% | 9.3 | 38,628 | Common Stock, no par value |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 9.56 per share. | 10 Mar 2025 | 200 | 689,878 (3%) | 0% | 9.6 | 1,913 | Common Stock, no par value |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 27.76 per share. | 06 Mar 2025 | 12,762 | 44,232 (0%) | 0% | 27.8 | 354,273 | Ordinary Shares |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 06 Mar 2025 | 6,650 | 37,582 (0%) | 0% | 27.8 | 184,604 | Ordinary Shares |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 5,485 | 5,485 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 2,163 | 0 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.76 per share. | 06 Mar 2025 | 2,163 | 39,745 (0%) | 0% | 27.8 | 60,045 | Ordinary Shares |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 1,759 | 1,758 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.68 per share. | 06 Mar 2025 | 1,759 | 40,377 (0%) | 0% | 28.7 | 50,448 | Ordinary Shares |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 06 Mar 2025 | 1,127 | 38,618 (0%) | 0% | 27.8 | 31,286 | Ordinary Shares |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.68 per share. | 06 Mar 2025 | 917 | 39,460 (0%) | 0% | 28.7 | 26,300 | Ordinary Shares |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 05 Mar 2025 | 6,259 | 690,078 (3%) | 0% | 9.4 | 58,895 | Common Stock, no par value |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 9.42 per share. | 05 Mar 2025 | 3,207 | 696,337 (3%) | 0% | 9.4 | 30,208 | Common Stock, no par value |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 9.40 per share. | 05 Mar 2025 | 534 | 699,544 (3%) | 0% | 9.4 | 5,020 | Common Stock, no par value |
| Donnelley Financial Soluti... | Robert Kirk Williams | Chief People & Admin Officer | Grant, award, or other acquisition of securities at price $ 47.54 per share. | 03 Mar 2025 | 9,960 | 66,979 (0%) | 0% | 47.5 | 473,498 | Common Stock |
| Donnelley Financial Soluti... | Robert Kirk Williams | Chief People & Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 9,742 | 74,472 (0%) | 0% | - | Common Stock | |
| Donnelley Financial Soluti... | Robert Kirk Williams | Chief People & Admin Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.54 per share. | 03 Mar 2025 | 6,784 | 60,195 (0%) | 0% | 47.5 | 322,511 | Common Stock |
| Donnelley Financial Soluti... | Robert Kirk Williams | Chief People & Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 4,535 | 64,730 (0%) | 0% | - | Common Stock | |
| Donnelley Financial Soluti... | Robert Kirk Williams | Chief People & Admin Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.54 per share. | 03 Mar 2025 | 1,964 | 57,019 (0%) | 0% | 47.5 | 93,369 | Common Stock |
| Donnelley Financial Soluti... | Robert Kirk Williams | Chief People & Admin Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.10 per share. | 03 Mar 2025 | 954 | 73,518 (0%) | 0% | 46.1 | 43,979 | Common Stock |
| Couchbase Inc | William Robert Carey | Interim CFO & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 27,625 | 98,750 | - | 0 | Common Stock | |
| Cognex Corp. | Robert J. Willett | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 193,201 | 193,201 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Robert J. Willett | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 70,824 | 70,824 | - | - | Restricted Stock Unit | |
| Regional Management Corp | Robert William Beck | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 36.71 per share. | 05 Feb 2025 | 13,000 | 101,673 (0%) | 0% | 36.7 | 477,230 | Common Stock |
| Regional Management Corp | Robert William Beck | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 18,451 | 114,673 (1%) | 0% | 0 | Common Stock | |
| Regional Management Corp | Robert William Beck | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.98 per share. | 31 Dec 2024 | 21,055 | 96,222 (0%) | 0% | 34.0 | 715,449 | Common Stock |
| Regional Management Corp | Robert William Beck | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 17,730 | 117,277 (1%) | 0% | - | Common Stock | |
| Regional Management Corp | Robert William Beck | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 17,730 | 35,461 | - | - | Restricted Stock Units | |
| Couchbase Inc | Carey Robert William | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.30 per share. | 16 Dec 2024 | 1,575 | 71,125 | - | 15.3 | 24,098 | Common Stock |
| Regional Management Corp | Beck Robert William | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 32.49 per share. | 04 Dec 2024 | 6,404 | 104,143 (0%) | 0% | 32.5 | 208,066 | Common Stock |
| Regional Management Corp | William Robert Beck | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 32.56 per share. | 04 Dec 2024 | 3,896 | 99,547 (0%) | 0% | 32.6 | 126,854 | Common Stock |
| Regional Management Corp | Beck William Robert | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 33.13 per share. | 04 Dec 2024 | 700 | 103,443 (0%) | 0% | 33.1 | 23,191 | Common Stock |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 10.45 per share. | 02 Dec 2024 | 15,000 | 700,078 (3%) | 0% | 10.5 | 156,752 | Common Stock, no par value |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 10.33 per share. | 02 Dec 2024 | 10,000 | 724,803 (3%) | 0% | 10.3 | 103,332 | Common Stock, no par value |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 10.54 per share. | 02 Dec 2024 | 9,725 | 715,078 (3%) | 0% | 10.5 | 102,523 | Common Stock, no par value |
| Consumer Portfolio Service... | B. Roberts William | Director | Sale of securities on an exchange or to another person at price $ 10.35 per share. | 26 Nov 2024 | 10,000 | 735,078 (3%) | 0% | 10.4 | 103,525 | Common Stock, no par value |
| Consumer Portfolio Service... | William Roberts B. | Director | Sale of securities on an exchange or to another person at price $ 10.27 per share. | 26 Nov 2024 | 275 | 734,803 (3%) | 0% | 10.3 | 2,825 | Common Stock, no par value |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 10.46 per share. | 21 Nov 2024 | 10,000 | 755,078 (3%) | 0% | 10.5 | 104,608 | Common Stock, no par value |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 10.64 per share. | 21 Nov 2024 | 10,000 | 745,078 (3%) | 0% | 10.6 | 106,440 | Common Stock, no par value |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 10.31 per share. | 21 Nov 2024 | 5,000 | 765,078 (3%) | 0% | 10.3 | 51,574 | Common Stock, no par value |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 10.49 per share. | 14 Nov 2024 | 15,000 | 770,078 (3%) | 0% | 10.5 | 157,350 | Common Stock, no par value |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 10.38 per share. | 14 Nov 2024 | 10,000 | 785,078 (3%) | 0% | 10.4 | 103,800 | Common Stock, no par value |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 10.37 per share. | 14 Nov 2024 | 5,000 | 795,078 (3%) | 0% | 10.4 | 51,850 | Common Stock, no par value |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 10.76 per share. | 11 Nov 2024 | 50,000 | 850,078 (3%) | 0% | 10.8 | 538,000 | Common Stock, no par value |
| Consumer Portfolio Service... | William B. Roberts | Director | Sale of securities on an exchange or to another person at price $ 10.46 per share. | 11 Nov 2024 | 50,000 | 800,078 (3%) | 0% | 10.5 | 523,000 | Common Stock, no par value |
| Tenaya Therapeutics Inc | Robert Sanders Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Couchbase Inc | William Robert Carey | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 20 Sep 2024 | 912 | 72,700 | - | 18 | 16,416 | Common Stock |
| Couchbase Inc | William Robert Carey | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 11.62 per share. | 20 Sep 2024 | 912 | 73,612 | - | 11.6 | 10,597 | Common Stock |
| Couchbase Inc | William Robert Carey | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.40 per share. | 16 Sep 2024 | 1,521 | 72,700 | - | 14.4 | 21,902 | Common Stock |
| Milestone Pharmaceuticals Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Couchbase Inc | William Robert Carey | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2024 | 27,655 | 74,221 | - | 0 | Common Stock | |
| W.R. Berkley Corp. | William Robert Berkley | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 120,430 | 4,447,876 (2%) | 0% | 0 | Common Stock | |
| W.R. Berkley Corp. | William Robert Berkley | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.75 per share. | 15 Aug 2024 | 5,055 | 4,442,821 (2%) | 0% | 57.7 | 291,926 | Common Stock |
| Oncternal Therapeutics Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 2,200 | 2,200 | - | - | Stock Options | |
| Couchbase Inc | William Robert Carey | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.24 per share. | 17 Jun 2024 | 1,531 | 46,566 | - | 17.2 | 26,394 | Common Stock |
| W.R. Berkley Corp. | William Robert Berkley | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,534 | 2,884,966 (1%) | 0% | 0 | Common Stock | |
| Regional Management Corp | Robert William Beck | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 53,191 | 53,191 | - | - | Restricted Stock Units | |
| Clean Harbors, Inc. | Robert J. Willett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 836 | 8,587 (0%) | 0% | 0 | Common Stock | |
| Regional Management Corp | Robert William Beck | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 May 2024 | 4,000 | 110,547 (1%) | 0% | 0 | Common Stock | |
| Donnelley Financial Soluti... | Robert Kirk Williams | Chief People & Admin Officer | Sale of securities on an exchange or to another person at price $ 63.57 per share. | 03 May 2024 | 18,229 | 58,983 (0%) | 0% | 63.6 | 1,158,814 | Common Stock |
| Donnelley Financial Soluti... | Robert Kirk Williams | Chief People & Admin Officer | Sale of securities on an exchange or to another person at price $ 63.83 per share. | 03 May 2024 | 855 | 77,212 (0%) | 0% | 63.8 | 54,577 | Common Stock |
| Regional Management Corp | Robert William Beck | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2024 | 18,530 | 123,134 (1%) | 0% | 0 | Common Stock | |
| Regional Management Corp | Robert William Beck | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.00 per share. | 12 Apr 2024 | 8,587 | 114,547 (1%) | 0% | 25 | 214,675 | Common Stock |
| Oncternal Therapeutics Inc | Robert J. Wills | Director | Purchase of securities on an exchange or from another person at price $ 8.96 per share. | 08 Apr 2024 | 3,086 | 10,000 (0%) | 0% | 9.0 | 27,655 | Common Stock |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 6,210 | 6,210 | - | - | Restricted Stock Units | |
| Oncternal Therapeutics Inc | Robert J. Wills | Director | Purchase of securities on an exchange or from another person at price $ 8.48 per share. | 28 Mar 2024 | 6,914 | 6,914 (0%) | 0% | 8.5 | 58,602 | Common Stock |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 67,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 49,245 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 32,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 30,000 | 0 (0%) | 0% | - | Common Stock | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 27,705 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 27,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 25,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 25,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 18,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 16,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 15,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 14,010 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 9,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 7,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Couchbase Inc | William Robert Carey | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 27.90 per share. | 21 Mar 2024 | 4,431 | 48,097 | - | 27.9 | 123,647 | Common Stock |
| Couchbase Inc | William Robert Carey | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.92 per share. | 18 Mar 2024 | 3,541 | 52,944 | - | 26.9 | 95,324 | Common Stock |
| Couchbase Inc | William Robert Carey | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 27.20 per share. | 18 Mar 2024 | 416 | 52,528 | - | 27.2 | 11,315 | Common Stock |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 2,163 | 2,163 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.69 per share. | 06 Mar 2024 | 2,163 | 32,595 (0%) | 0% | 29.7 | 64,219 | Ordinary Shares |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 1,759 | 3,517 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.09 per share. | 06 Mar 2024 | 1,759 | 31,347 (0%) | 0% | 28.1 | 49,410 | Ordinary Shares |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.69 per share. | 06 Mar 2024 | 1,125 | 31,470 (0%) | 0% | 29.7 | 33,401 | Ordinary Shares |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.09 per share. | 06 Mar 2024 | 915 | 30,432 (0%) | 0% | 28.1 | 25,702 | Ordinary Shares |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 05 Mar 2024 | 7,291 | 33,380 (0%) | 0% | 27.3 | 198,753 | Ordinary Shares |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.26 per share. | 05 Mar 2024 | 3,792 | 29,588 (0%) | 0% | 27.3 | 103,370 | Ordinary Shares |
| Perrigo Company plc | Robert Willis | EVP & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.26 per share. | 05 Mar 2024 | 1,279 | 26,755 (0%) | 0% | 27.3 | 34,866 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges